FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults

FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults

Source: FDA Center for Drug Evaluation and Research - What's New - June 15, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news